SecBot SecBot
SECBOTREPLAY Home › Report › VRTX

VRTX · Two executives at Vertex Pharmaceuticals executed open-market share…

VERTEX PHARMACEUTICALS INC / MA · CLUSTER filed Feb 24, 2026 at 19:00 ET

At the news

NEUTRALIMPACT 3/10

CLUSTER filed Feb 24, 2026 at 19:00 ET

Two executives at Vertex Pharmaceuticals executed open-market share sales totaling $433K, while the same insiders also surrendered shares for tax withholding purposes related to equity compensation. The open-market sales are modest in value relative to the company's $122.5B market cap.

  • EVP Edward Atkinson sold 668 shares for $324,881.80 in an open-market transaction.
  • SVP Kristen Ambrose sold 223 shares for $108,456.05 in an open-market transaction.
  • Both executives also surrendered shares to cover tax liabilities from equity vesting: Atkinson (1,627 shares, $789,273.97) and Ambrose (546 shares, $264,870.06).
  • Total open-market proceeds: $433,337.85; total tax-related share surrenders: ~$1.05M.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access